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General Considerations. Unless otherwise specified, all operations involving air- or water-sensitive reagents were 
carried out in an MBraun drybox under a nitrogen atmosphere or using standard Schlenk and vacuum line techniques. 
Solvents for air- and moisture-sensitive reactions were dried by the method of Grubbs.1 Deuterated solvents were 
purchased from Cambridge Isotope Laboratories and C6D6 vacuum transferred from sodium benzophenone ketyl 
before use. All solvents, once dried and degassed, were stored under a nitrogen atmosphere over 4 Å molecular sieves. 
Sodium hydride dispersion in oil was washed with multiple times with hexanes and dried in vacuo before used.  4-
tert-butyl-2,6-dibromophenol,2 chloromethyl methyl ether solution,3 tetrabenzylzirconium,4 and Mg(THF)3(C14H10)5 
were prepared according to literature procedures. Alkynes and nitriles used were either sublimed under reduced 
pressure or distilled from calcium hydride before use. All other reagents were used as received. 1H, 13C{1H}, and 19F 
NMR spectra were recorded on Varian Mercury 300 MHz or Varian 400 MHz spectrometers at ambient temperatures, 
unless otherwise denoted. 1H and 13C{1H} NMR spectra are reported referenced internally to residual solvent peaks 
reported relative to tetramethylsilane. 19F NMR chemical shifts are referenced to external standard of C6F6 (-164.9 
ppm). Fast atom bombardment-mass spectrometry (FAB-MS) analyses were performed with a JEOL JMS-600H high 
resolution mass spectrometer. Gas chromatography-mass spectrometry (GC-MS) were performed with on an Agilent 
6890A instrument using a HP-5MS column (30 m length, 0.25 mm diameter, 0.50 μm film) and an Agilent 5973N 
mass-selective EI detector. Photolyses were conducted using an Oriel Instruments arc lamp housing and a Osram 75 
W Xe arc lamp set to a current of 5.4 A. 
 
Experimental 
 1,3-dibromo-5-(tert-butyl)-2-(methoxymethoxy)benzene. To a solution of 2,6-dibromo-4-(tert-butyl)phenol (100 g, 
325 mmol) in THF (500 mL) at 0 °C was added portion-wise NaH (11.7 g, 487 mmol) slowly (caution: effervescence). 
After stirring for an additional 30 min, a toluene solution of chloromethyl methyl ether (232 mL, 487 mmol, 2.1 M) 
was added slowly at 0 °C. After complete addition, the reaction was allowed to warm up to room temperature and 
stirred an additional 2 h. The reaction was quenched by the slow addition of water (50 mL) and was then concentrated 
to ca. 200 mL under vacuum. The remaining suspension was partitioned between water (300 mL) and CH2Cl2 (200 
mL). The organic layer was separated and the aqueous layer extracted with CH2Cl2 (2 × 200 mL). The combined 
organic extracts was then dried over MgSO4, filtered and concentrated in vacuo to provide a pale yellow oil (106.8 g, 
98.4%). The product was further dried by stirring over calcium hydride and filtering before using in the next step. 1H 
NMR (400 MHz, CDCl3): δ 7.50 (s, 2H, ArH), 5.15 (s, 2H, CH2), 3.72 (s, 3H, OCH3), 1.28 (s, 9H, C(CH3)3); 13C{1H} 
NMR (101 MHz, CDCl3): δ 150.28 (aryl-C), 149.13 (aryl-C), 130.20 (aryl-C), 118.02 (aryl-C), 99.66 (CH2), 58.58 
(OCH3), 34.72 (C(CH3)3), 31.26 (C(CH3)3); HRMS (FAB+) m/z Calcd. for C12H16Br2O2 [(M + H) – H2]+ 350.9418, 
found 350.9406. 
 3-bromo-5-(tert-butyl)-2-(methoxymethoxy)-2',4',6'-trimethyl-1,1'-biphenyl. A Schlenk flask fitted with a screw-
in Teflon stopper was charged with a solution of 2-bromomesitylene (24.1 mL, 157 mmol) in THF (500 mL) and 
cooled to –78 °C. A pentane solution of tert-butyllithium (174 mL, 1.9 M, 331 mmol) was added dropwise via cannula. 
The reaction was allowed to warm to room temperature and stirred for 1 h forming an orange solution. The reaction 
was then brought into a N2-purged glovebox and ZnCl2 (15.1 g, 110 mmol) was added slowly to the reaction resulting 
in the loss of the orange coloration. The mixture was allowed to stir at room temperature for 30 min. 1,3-dibromo-5-
(tert-butyl)-2-(methoxymethoxy)benzene (50.0 g, 142 mmol) and Pd(PPh3)4 (1.82 g, 1.57 mmol) was added, the flask 
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sealed and warmed to 70 °C for 36 h. After cooling to room temperature, water (50 mL) was added to quench the 
reaction, and the mixture concentrated in vacuo to about 100 mL. The resulting suspension was taken up in CH2Cl2 
(200 mL) and filtered through a silica gel plug, eluting further with CH2Cl2. The filtrate was then washed with water 
(2 × 200 mL), dried over MgSO4, filtered and concentrated in vacuo to afford the crude product as a pale yellow oil. 
The crude mixture can be purified via Kugelrohr distillation, providing the desired product as a viscous colorless oil 
that crystallizes on standing (41.2 g, 74.1%). 1H NMR (400 MHz, CDCl3): δ 7.56 (d, 4JH,H = 2.2 Hz, 1H, ArH), 7.06 
(d, 4JH,H = 2.2 Hz, 1H, ArH) 6.94 (s, 2H, ArH) 4.70 (s, 2H, CH2), 2.99 (s, 3H, OCH3), 2.32 (s, 3H, ArCH3), 2.05 (s, 
6H, ArCH3) 1.30 (s, 9H, C(CH3)3); 13C{1H} NMR (101 MHz, CDCl3): δ 149.23 (aryl-C), 148.72 (aryl-C), 137.18 
(aryl-C), 136.83 (aryl-C), 135.43 (aryl-C; coincidental overlap), 129.34 (aryl-C), 128.31 (aryl-C), 128.14 (aryl-C), 
117.64 (aryl-C), 98.67 (CH2), 56.88 (OCH3), 34.64 (C(CH3)3), 31.44 (C(CH3)3), 21.18 (ArCH3), 20.72 (ArCH3); 
HRMS (FAB+) m/z Calcd. for C21H27BrO2 [(M + H) – H2]+ 391.1096, found 391.1099. 
 
Anti-9,10-bis(5-(tert-butyl)-2-(methoxymethoxy)-2',4',6'-trimethyl-[1,1'-biphenyl]-3-yl)anthracene. A Schlenk 
flask fitted with a screw-in Teflon stopper was charged with a solution of 3-bromo-5-(tert-butyl)-2-
(methoxymethoxy)-2',4',6'-trimethyl-1,1'-biphenyl (20.0 g, 50.1 mmol) in THF (200 mL) and cooled to –78 °C. A 
pentane solution of tert-butyllithium (56.5 mL, 1.9 M, 107 mmol) was added dropwise via cannula. The reaction was 
allowed to warm to room temperature and stirred for 1 h forming a dark orange solution. The reaction was then brought 
into a N2-purged and ZnCl2 (4.89 g, 35.9 mmol) was added slowly to the reaction resulting in the formation of a cloudy 
pale yellow mixture. The reaction was allowed to stir at room temperature for 30 min after which 9,10-
dibromoanthracene (7.73 g, 23.0 mmol) and Pd(PPh3)4 (591 mg, 0.51 mmol) was added. The flask was sealed and 
warmed to 70 °C for 48 h. After cooling to room temperature, water (20 mL) was added to quench the reaction, and 
the mixture concentrated in vacuo to about 50 mL. The resulting suspension was taken up in CH2Cl2 (200 mL) and 
filtered through a silica gel plug, eluting further with CH2Cl2. The filtrate was then washed with water (2 × 200 mL), 
dried over MgSO4, filtered and concentrated in vacuo to afford the crude product as a sticky yellow solid which was 
triturated in MeOH (250 mL) with aid of sonication, filtered and dried in vacuo to provide the product as a pale yellow 
powder (16.2 g, 88.2%). 1H NMR (400 MHz, CDCl3): δ 7.77 (app dd, JH,H = 6.8, 3.3 Hz, 4H, anth–H), 7.38 (app dd, 
JH,H = 6.8, 3.3 Hz, 4H, anth–H), 7.33 (d, 4JH,H = 2.5 Hz, 2H, ArH), 7.27 (d, 4JH,H = 2.5 Hz, 2H, ArH), 6.97 (s, 4H, 
ArH), 4.06 (s, 4H, CH2), 2.33 (s, 6H, ArCH3), 2.27 (s, 12H, ArCH3), 2.10 (s, 6H, OCH3), 1.35 (s, 18H, C(CH3)3); 
13C{1H} NMR (101 MHz, CDCl3): δ 151.09 (aryl-C), 147.11 (aryl-C), 136.94 (aryl-C), 136.78 (aryl-C), 136.27 (aryl-
C), 134.72 (aryl-C), 134.29 (aryl-C), 132.29 (aryl-C), 130.34 (aryl-C), 129.11 (aryl-C), 128.64 (aryl-C), 128.15 (aryl-
C), 127.18 (aryl-C), 125.25 (aryl-C), 97.98 (CH2), 55.42 (OCH3), 34.70 (C(CH3)3), 31.72 (C(CH3)3), 21.21 (ArCH3), 
21.04 (ArCH3); HRMS (FAB+) m/z Calcd. for C56H62O4 [M]+ 798.4648, found 798.4674. 
 
Anti-3,3''-(anthracene-9,10-diyl)bis(5-(tert-butyl)-2',4',6'-trimethyl-[1,1'-biphenyl]-2-ol). A Schlenk flask fitted 
with a screw-in Teflon stopper was charged with anti-9,10-bis(5-(tert-butyl)-2-(methoxymethoxy)-2',4',6'-trimethyl-
[1,1'-biphenyl]-3-yl)anthracene (15.0 g, 18.8 mmol), MeOH (100 mL) and CH2Cl2 (200 mL). Concentrated aqueous 
HCl (20 mL) was added, the flask sealed and heated to 45 °C, monitoring the progress of the reaction via 1H NMR 
spectroscopy. After complete deprotection, about 6 h, the reaction was cooled and concentrated in vacuo. The 
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suspension was taken up in CH2Cl2 (250 mL) and washed with H2O (2 × 200 mL) and then saturated aqueous NaHCO3 
(100 mL). The organic fraction was dried over MgSO4, filtered and concentrated under reduced pressure to provide 
the product as a pale yellow solid (13.2 g, 98.9%). 1H NMR (400 MHz, CDCl3): δ 7.80 (app dd, JH,H = 6.8, 3.3 Hz, 
4H, anth–H), 7.41 (app dd, JH,H = 6.8, 3.0 Hz, 4H, anth–H), 7.34 (d, 4JH,H = 2.5 Hz, 2H, ArH), 7.27 (d, 4JH,H = 2.5 Hz, 
2H, ArH), 7.03 (s, 4H, ArH), 4.47 (s, 2H, OH), 2.35 (s, 6H, ArCH3), 2.22 (s, 12H, ArCH3), 1.35 (s, 18H, C(CH3)3); 
13C{1H} NMR (101 MHz, CDCl3): δ 148.56 (aryl-C), 143.58 (aryl-C), 137.67 (aryl-C), 137.50 (aryl-C), 133.68 (aryl-
C), 133.28 (aryl-C), 130.73 (aryl-C), 128.76 (aryl-C), 128.68 (aryl-C), 127.64 (aryl-C), 126.94 (aryl-C), 126.54 (aryl-
C), 125.72 (aryl-C), 124.03 (aryl-C), 34.55 (C(CH3)3), 31.86 (C(CH3)3), 21.28 (ArCH3), 20.67 (ArCH3); HRMS 
(FAB+) m/z Calcd. for C52H54O2 [M]+ 710.4124, found 710.4142. 
 
 
Syn-3,3''-(anthracene-9,10-diyl)bis(5-(tert-butyl)-2',4',6'-trimethyl-[1,1'-biphenyl]-2-ol) (LH2). A suspension of 
the anti atropisomer (13.0 g) in degassed xylenes (80 mL) was heated to reflux under N2 for 6 h after which the yellow 
solution was cooled to room temperature and the volatiles removed in vacuo. The isomeric mixture was separated by 
silica gel column chromatography, eluting first with 1:4 CH2Cl2:hexanes to separate the anti-isomer, and then 1:3:16 
EtOAc:CH2Cl2:hexanes to obtain the desired syn-isomer LH2 as a white to pale yellow solid after drying in vacuo 
(6.08 g 46.8%). The anti-isomer obtained (6.31 g, 48.5%) can be further isomerized and separated again by silica gel 
column chromatography to provide more desired syn-isomer. 1H NMR (400 MHz, CDCl3): δ 7.81 (app dd, JH,H = 6.8, 
3.2 Hz, 4H, anth–H), 7.43 (dd, JH,H = 6.8, 3.2 Hz, 4H, anth–H), 7.31 (d, 4JH,H = 2.5 Hz, 2H, ArH), 7.28 (d, 4JH,H = 2.5 
Hz, 2H, ArH), 7.01 (s, 4H, ArH), 4.50 (s, 2H, OH), 2.34 (s, 6H, ArCH3), 2.21 (s, 12H, ArCH3), 1.35 (s, 18H, C(CH3)3); 
13C{1H} NMR (101 MHz, CDCl3): δ 148.59 (aryl-C), 143.50 (aryl-C), 137.62 (aryl-C), 137.42 (aryl-C), 133.77 (aryl-
C), 133.35 (aryl-C), 130.75 (aryl-C), 128.65 (aryl-C), 128.62 (aryl-C), 127.74 (aryl-C), 126.93 (aryl-C), 126.60 (aryl-
C), 125.79 (aryl-C), 123.92 (aryl-C), 34.53 (C(CH3)3), 31.85 (C(CH3)3), 21.27 (ArCH3), 20.69 (ArCH3); HRMS 
(FAB+) m/z Calcd. for C52H54O2 [M]+ 710.4124, found 710.4089. 
 
 Synthesis of 1. All manipulations for this reaction until the workup was carried out in the glovebox in the absence of 
light to the extent possible. To a thawing solution of tetrabenzylzirconium (320.5 mg, 0.703 mmol) in toluene (20 
mL), was added a thawing solution of LH2 (500 mg, 0.703 mmol) in toluene (10 mL) with stirring. The reaction was 
allowed to warm up to room temperature and stirred an additional 2 h, forming a yellow solution. The solution was 
filtered through a pad of diatomaceous earth and volatiles were removed in vacuo to afford 2 as a yellow solid (681 
mg 98.6%). X-Ray quality single crystals were grown by slow diffusion of pentane into a saturated toluene solution 
at –35 °C. 1H NMR (400 MHz, C6D6): δ 8.06 (app dd, JH,H = 6.7, 3.2 Hz, 4H, anth–H), 7.95 (d, 4JH,H = 2.6 Hz, 2H, 
ArH), 7.20 (d, 4JH,H = 2.5 Hz, 2H, ArH), 7.12 (app dd, J = 6.7, 3.2 Hz, 4H, anth–H), 6.80 (s, 4H, MesH), 6.78 – 6.66 
(m, 6H, ArH), 5.86 (d, J = 7.2 Hz, 4H, ArH), 2.21 (s, 6H, ArCH3), 2.09 (s, 12H, ArCH3), 1.38 (s, 18H, C(CH3)3), 0.87 
(s, 4H, PhCH2); 13C{1H} NMR (101 MHz, C6D6): δ 157.10 (aryl-C), 143.83 (aryl-C), 139.69 (aryl-C), 137.13 (aryl-
C), 136.68 (aryl-C), 136.35 (aryl-C), 134.58 (aryl-C), 131.62 (aryl-C), 131.47 (aryl-C), 130.75 (aryl-C), 130.44 (aryl-
C), 128.44 (aryl-C), 127.82 (aryl-C), 127.75 (aryl-C), 126.75 (aryl-C), 126.37 (aryl-C), 124.69 (aryl-C), 123.85 (aryl-
C), 59.46 (PhCH2), 34.55 (C(CH3)3), 31.93 (C(CH3)3), 21.36 (ArCH3), 21.19 (ArCH3); Anal. Calcd. C66H66O2Zr (%): 
C, 80.69; H, 6.77. Found: C, 80.84; H, 6.62. 
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 Synthesis of 2. A solution of 1 (1.00 g, 1.02 mmol) in THF (80 mL) was irradiated with light from a Xe arc lamp (75 
W) with stirring. After 24 h, the volatiles were removed in vacuo, and the residue triturated with hexanes twice. 
Pentane (10 mL) was added and cooled to –35 °C overnight to allow precipitation. The suspension was filtered and 
the residue washed with cold pentane (5 mL), and then room temperature pentane (2 × 3 mL). The residue was 
extracted with diethyl ether and dried in vacuo to provide 2 as a deep red solid (587 mg 56.9%). X-ray quality single 
crystals were grown by cooling a saturated pentane to –35 °C. 1H NMR (400 MHz, C6D6): δ 7.88 (d, 4JH,H = 2.5 Hz, 
2H, ArH), 7.34 (app dd, JH.H = 5.7, 3.3 Hz, 4H, anth–H), 7.15 (d, 4JH,H = 2.5 Hz, 2H, ArH), 6.90 (app dd, JH,H = 5.7, 
3.2 Hz, 4H, anth–H), 6.82 (s, 4H, MesH), 3.61 – 3.54 (m, 8H, THF-OCH2), 3.18 – 3.11 (m, 4H, THF), 2.20 (s, 6H, 
ArCH3), 2.16 (s, 12H, ArCH3), 1.42 (s, 18H, C(CH3)3), 1.08 (m, 12H, THF-CH2); 13C{1H} NMR (101 MHz, C6D6): δ 
161.54 (aryl-C), 140.71 (aryl-C), 140.40 (aryl-C), 139.39 (aryl-C), 136.78 (aryl-C), 135.71 (aryl-C), 135.11 (aryl-C), 
127.50 (aryl-C), 126.42 (aryl-C), 128.30 (aryl-C), 124.22 (2C, aryl-C), 123.12 (aryl-C), 94.78 (Zr-C), 73.82 (THF-
OCH2), 69.55 (THF-OCH2), 34.44 (C(CH3)3), 32.38 (C(CH3)3), 25.39 (THF-CH2), 24.80 (THF-CH2), 21.45 (ArCH3), 
21.16 (ArCH3). Anal. Calcd. C64H73O5Zr (%): C, 75.85; H, 7.26. Found: C, 75.48; H, 6.97. 
 Synthesis of 3a. A solution of 2 (100 mg, 0.0986 mmol) and diphenylacetylene (35.2 mg, 0.197 mmol) in benzene (5 
mL) was heated to 90 °C with stirring for 3 h. After cooling to room temperature, the volatiles were removed in vacuo. 
The residue was washed with cold pentane, extracted with benzene and filtered through diatomaceous earth. 
Concentration under vacuum provided 3a as a yellow solid (89.6 mg 74.0%). X-ray quality single crystals were grown 
by slow diffusion of pentane into a saturated toluene solution at –35 °C. 1H NMR (400 MHz, C6D6): δ  8.01 (app dd, 
JH,H = 6.7, 3.3 Hz, 2H, anth–H), 7.94 (d, 4JH,H = 2.5 Hz, 2H, ArH), 7.92 (app dd, JH,H = 6.8, 3.2 Hz, 2H, anth–H), 7.45 
(d, 4JH,H = 2.6 Hz, 2H, ArH), 7.29 (s, 2H, MesH), 7.02 (s, 2H, MesH), 6.88 – 6.49 (m, 22H, ArH), 5.46 (d, 3JH,H = 7.5 
Hz, 2H, ArH), 3.00 (s, 6H, ArCH3), 2.71 (s, br, 4H, THF-OCH2), 2.35 (s, 6H, ArCH3), 2.08 (s, 6H, ArCH3), 1.43 (s, 
18H, C(CH3)3), 0.37 (s, br, 4H, THF-CH2). 13C{1H} NMR (101 MHz, C6D6): δ 197.61 (ZrC), 193.83 (ZrC), 159.82 
(ZrC(Ph)C), 157.29 (aryl-C), 154.70 (ZrC(Ph)C), 149.30 (aryl-C), 148.74 (aryl-C), 143.06 (aryl-C), 142.23 (aryl-C), 
142.10 (aryl-C), 138.96 (aryl-C), 136.98 (aryl-C), 136.36 (aryl-C), 135.83 (aryl-C), 133.42 (aryl-C), 131.35 (aryl-C), 
131.19 (aryl-C), 130.38 (aryl-C), 130.32 (aryl-C), 130.04 (aryl-C), 129.56 (aryl-C), 128.90 (aryl-C), 128.75 (aryl-C), 
128.22 (aryl-C), 128.01 (aryl-C), 127.42 (aryl-C), 127.33 (aryl-C), 127.06 (aryl-C), 126.53 (aryl-C), 126.26 (aryl-C), 
126.13 (aryl-C), 125.91 (aryl-C), 125.27 (aryl-C), 124.78 (aryl-C), 124.62 (aryl-C), 124.53 (aryl-C), 124.41 (aryl-C), 
122.69 (aryl-C), 122.40 (aryl-C), 70.68 (THF-OCH2), 34.61 (C(CH3)3), 32.00 (C(CH3)3), 23.72 (THF-OCH2CH2), 
22.66 (ArCH3), 21.40 (ArCH3), 21.28 (ArCH3); Anal. Calcd. C84H79O3Zr (%): C, 82.17; H, 6.49. Found: C, 81.98; H, 
6.72. 
 
S7 
 
Synthesis of 3b. Phenylacetylene (22 µL, 0.20 mmol) was added to a stirred solution of 2 (100 mg, 0.099 mmol) in 
benzene (5 mL) at room temperature resulting in red-brown to a yellow-brown color change. After 10 min, the volatiles 
were removed in vacuo and the residue extracted with pentane and filtered over diatomaceous earth. Drying under 
reduced pressure provided 3b as an orange powder (77.6 mg, 73.3%). X-ray quality single crystals were grown by 
slow diffusion of pentane into a saturated benzene solution at room temperature. 1H NMR (400 MHz, C6D6): δ 8.28 
(app dd, JH,H = 6.8, 3.3 Hz, 2H, anth–H), 7.96 (d, 4JH,H = 2.5 Hz, 2H, ArH), 7.41 (d, J = 7.7 Hz, 2H, ArH), 7.36 (d, 
4JH,H = 2.6 Hz, 2H, ArH), 7.28 – 7.19 (m, 5H, ArH),  7.09 (t, J = 7.7 Hz, 1H, ArH), 7.04 (d, 4JH,H = 4.3 Hz, 1H, ZrCH), 
6.96 (t, J = 7.4 Hz, 2H), 6.91 (s, 2H, MesH), 6.90 (s, 2H, MesH), 6.88 – 6.81 (m, 3H), 6.22 (d, 4JH,H = 4.5 Hz, 1H, 
ZrC(Ph)CH), 5.87 (d, 3JH,H = 7.3 Hz, 2H, ArH), 2.52 (app t, br, 3JH,H = 5.7 Hz, 4H, THF-OCH2), 2.39 (s, 6H, ArCH3), 
2.24 (s, 6H, ArCH3), 2.10 (s, 6H, ArCH3), 1.44 (s, 18H, C(CH3)3), 0.51 (app t, br, 3JH,H = 5.7 Hz, 4H, THF-CH2); 
13C{1H} NMR (101 MHz, C6D6): δ 199.14 (ZrC), 188.17 (ZrC), 156.93 (aryl-C), 155.93 (ZrC(Ph)), 150.75 (aryl-C), 
146.99 (ZrCH), 143.97 (aryl-C), 142.80 (aryl-C), 139.24 (aryl-C), 136.58 (aryl-C), 136.45 (aryl-C), 135.32 (aryl-C), 
135.04 (aryl-C), 131.91 (aryl-C), 131.26 (aryl-C), 131.18 (aryl-C), 130.08 (aryl-C), 129.04 (aryl-C), 128.59 (aryl-C), 
128.06 (aryl-C), 127.56 (aryl-C), 127.51 (aryl-C), 127.49 (aryl-C), 126.93 (aryl-C), 126.63 (aryl-C), 126.46 (aryl-C), 
125.96 (aryl-C), 125.70 (aryl-C), 125.45 (aryl-C), 124.47 (aryl-C), 123.24 (aryl-C), 70.52 (THF-OCH2), 34.61 
(C(CH3)3), 32.06 (C(CH3)3), 24.43 (THF-OCH2CH2), 21.31 (ArCH3), 21.28 (ArCH3), 21.07 (ArCH3); Anal. Calcd. 
C72H71O3Zr (%): C, 80.40; H, 6.65. Found: C, 80.67; H, 6.74. 
 
 Synthesis of 4. Method A: A J. Young NMR tube charged with a solution of 2 (20.0 mg, 0.197 mmol) and 
diphenylacetylene (7.0 mg, 0.039 mmol) in C6D6 (0.6 mL) was heated to 90 °C. After 2 h, the atmosphere in the tube 
was degassed and replaced with CO (1 atm) and the tube was heated for an additional 9 h after which 1H NMR 
spectroscopy showed that the major product matched that of 4 synthesized via method B. Method B: To a solution of 
2 (100 mg, 0.099 mmol) in benzene (5 mL) was added tetraphenylcyclopentadienone (37.9 mg, 0.099 mmol) at room 
temperature resulting in a red to yellow-brown color change. After 10 min, the volatiles were removed in vacuo and 
the solid residue washed with pentane and dried under reduced pressure to provide 4 as a dark brown powder (92.6 
mg, 68.0%). 1H NMR (400 MHz, C6D6): δ 7.93 – 7.89 (m, 6H, overlapping anth–H and ArH), 7.56 (dd, JH,H = 8.2, 1.3 
Hz, 4H, ArH), 7.33 (d, 4JH,H = 2.6 Hz, 2H, ArH), 7.20 (dd, JH,H = 8.0, 1.3 Hz, 4H, ArH), 7.08 (s, 4H, ArH), 7.04 (t, 
3JH,H = 7.6 Hz, 4H, ArH), 6.92 – 6.83 (m, 6H, ArH), 6.83 (dd, JH,H = 6.7, 3.3 Hz, 4H, ArH), 6.65 (t, 3JH,H = 7.3 Hz, 
2H, ArH), 2.83 (t, 3JH,H = 6.6 Hz, 8H, THF-OCH2), 2.36 (s, 6H, ArCH3), 2.22 (s, 12H, ArCH3), 1.36 (s, 18H, C(CH3)3), 
0.61 (d, 3JH,H = 6.1 Hz, 8H, THF-CH2); 13C{1H} NMR (101 MHz, C6D6): δ 156.95 (C=O), 144.31 (aryl-C), 143.70 
(aryl-C), 142.48 (aryl-C), 137.87 (aryl-C), 136.14 (aryl-C), 134.57 (aryl-C), 133.49 (aryl-C), 132.87 (aryl-C), 131.88 
(aryl-C), 131.35 (aryl-C), 131.28 (aryl-C), 130.22 (aryl-C), 129.99 (aryl-C), 129.05 (aryl-C), 128.59 (aryl-C), 127.19 
(aryl-C), 126.66 (aryl-C), 125.69 (aryl-C), 125.23 (aryl-C), 124.92 (aryl-C), 122.89 (aryl-C), 120.83 (aryl-C), 118.86 
(PhC), 110.21 (PhC), 73.46 (THF-OCH2), 34.56 (C(CH3)3), 31.81 (C(CH3)3), 22.90 (THF-OCH2CH2), 21.59 (ArCH3), 
21.46 (ArCH3); Anal. Calcd. C89H86O5Zr (%): C, 80.56; H, 6.53. Found: C, 80.32; H, 6.28. 
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Synthesis of 5. p-Tolunitrile (23.2 mg, 0.198 mmol) was added to a solution of 2 (100 mg, 0.099 mmol) in benzene 
(5 mL) at room temperature resulting in the immediate formation of a deep purple solution. After 5 min, the volatiles 
were removed in vacuo. The resulting solid was taken up in benzene (5 mL) and phenylacetylene (10.8 µL, 0.099 
mmol) was added forming a red-orange solution. After stirring an additional 10 min, the reaction was concentrated 
under vacuum and the residue washed with cold pentane and dried to provide 5 as a red brown solid (76.8 mg, 71.4%). 
X-ray quality single crystals were grown by slow diffusion of pentane into a saturated benzene solution at room 
temperature. 1H NMR (400 MHz, C6D6): δ 8.34 (app dd, JH,H = 6.8, 3.2 Hz, 2H, anth–H), 8.05 (app dd, JH,H = 6.7, 3.3 
Hz, 2H), 7.99 (d, 4JH,H = 2.5 Hz, 2H, ArH), 7.67 (d, 2JH,H = 8.1 Hz, 2H, Tol–H), 7.47 (app dd, JH,H = 6.8, 3.3 Hz, 2H), 
7.35 (d, J = 2.5 Hz, 2H, ArH), 7.28 (s, 1H, alkenyl–H), 7.04 (d, 2JH,H = 8.0 Hz, 2H, Tol–H), 6.97 (t, 2JH,H = 7.6 Hz, 
2H, ArH), 6.91 (s, 2H, MesH), 6.87 (m, 3H, anth–H and ArH), 6.83 (s, 2H, MesH), 5.84 (dd, JHH = 8.1, 1.4 Hz, 2H, 
ArH), 2.63 – 2.55 (m, 4H, THF-CH2), 2.24 (s, 6H, ArCH3), 2.23 (s, 6H, ArCH3), 2.16 (s, 3H, ArCH3), 2.11 (s, 6H, 
ArCH3), 1.44 (s, 18H, C(CH3)3), 0.57 – 0.47 (m, 4H, THF-CH2); 13C{1H} NMR (101 MHz, CDCl3): δ 210.36, 177.99, 
156.96, 150.94, 147.50, 142.07, 140.20, 139.05, 136.75, 136.28, 135.59, 135.46, 135.06, 131.76, 130.85, 129.83, 
129.62, 129.59, 128.97, 128.87, 128.43, 128.30, 127.95, 127.61, 127.54, 126.98, 126.77, 125.32, 124.78, 124.53, 
70.92 (THF-OCH2), 34.59 (C(CH3)3), 32.11 (C(CH3)3), 24.52 (THF-OCH2CH2), 21.48 (ArCH3), 21.28 (ArCH3), 21.25 
(ArCH3), 20.81 (ArCH3); Anal. Calcd. C72H72NO3Zr (%): C, 79.30; H, 6.65; N, 1.28. Found: C, 79.63; H, 6.41; N, 
1.66. 
 
General Setup for Catalytic Pyrimidine Synthesis. In the glovebox, stock solutions of nitrile, alkyne, 1-adamantane 
(internal standard), and 2 in the appropriate solvent were measured with syringes and added in that order to a vial 
equipped with a Teflon-coated stir bar, additional solvent was added to ensure total volume of the reaction was 3 mL. 
The vial was capped with a PTFE-lined septum cap, taken out of the box, and placed into a preheated heating block 
at the appropriate temperature. After the reaction time, the reaction was cooled to room temperature and quenched by 
exposure to air with stirring. A small volume was taken, filtered through a pad of silica gel, and eluted with CH2Cl2 
for GC-MS analysis. Parallel runs were also set up in the absence of 1-adamantane to obtain isolated yields. 
 
2,4,6-Triphenylpyrimidine (6a).6 Synthesized using the general setup using phenylacetylene (10.8 µL, 0.0987 
mmol), benzonitrile (61.0 µL, 0.592 mmol) and 2 (5.0 mg, 4.9 µmol) in toluene (3 mL), and purified via silica gel 
column chromatography (5% EtOAc/hexanes). White solid. First run 28.8 mg (95%). Second run 28.5 mg (94%). 
 
4,5-dibutyl-2,6-diphenylpyrimidine (6b).6 Synthesized using the general setup using 5-decyne (17.8 µL, 0.0987 
mmol), benzonitrile (61.0 µL, 0.592 mmol) and 2 (5.0 mg, 4.9 µmol) in toluene (3 mL), and purified via silica gel 
column chromatography (5% CH2Cl2/hexanes). White solid. First run 32.8 mg (96%) Second Run 32.6 mg (96%). 
 
2,6-diphenyl-4-(trimethylsilyl)pyrimidine (6c). Synthesized using the general setup using trimethylsilylacetylene 
(14.1 µL, 0.0987 mmol), benzonitrile (61.0 µL, 0.592 mmol) and 2 (5.0 mg, 4.9 µmol) in toluene (3 mL), and purified 
via silica gel column chromatography (5% CH2Cl2, 1% triethylamine in hexanes). White solid. First run 29.2 mg 
(97%) Second Run 28.9 mg (96%). 1H NMR (400 MHz, CDCl3): δ 8.80 (dd, J = 8.1, 1.6 Hz, 1H), 8.67 (dd, J = 8.0, 
1.8 Hz, 2H), 8.24 (dd, J = 7.8, 1.8 Hz, 2H), 7.78 (s, 1H), 7.66 – 7.46 (m, 5H), 0.43 (s, 9H); 13C{1H} NMR (101 MHz, 
CDCl3): δ 178.35, 171.78, 163.32, 161.71, 138.68, 137.89, 136.39, 132.63, 130.67, 130.46, 129.10, 128.98, 128.77, 
128.51, 128.49, 127.36, 119.46, -2.02; HRMS (FAB+) m/z Calcd. for C19H21SiN2 [M+H]+ 305.1474, found 305.1465. 
 
6-phenyl-2,4-di(p-tolyl)pyrimidine (6d).7 Synthesized using the general setup using phenylacetylene (10.8 µL, 
0.0987 mmol), p-tolunitrile (69.4 mg, 0.592 mmol) and 2 (5.0 mg, 4.9 µmol) in toluene (3 mL), and purified via silica 
gel column chromatography (5% EtOAc/hexanes). White solid. First run 31.9 mg (96%) Second Run 31.7 mg (95%). 
 
2,4-di(4-fluorophenyl)-6-phenylpyrimidine (6e). Synthesized using the general setup using phenylacetylene (10.8 
µL, 0.0987 mmol), 4-fluorobenzonitrile (71.7 mg, 0.592 mmol) and 2 (5.0 mg, 4.9 µmol) in toluene (3 mL), and 
purified via silica gel column chromatography (5% EtOAc/hexanes). White solid. First run 33.0 mg (97%) Second 
Run 32.9 mg (97%). 1H NMR (400 MHz, CDCl3): δ 8.75 – 8.67 (m, 2H), 8.31 – 8.23 (m, 4H), 7.94 (s, 1H), 7.59 – 
7.54 (m, 3H), 7.28 – 7.18 (m, 4H); 13C{1H} NMR (101 MHz, CDCl3): δ 165.00, 164.95 (d, 1JCF = 235.7 Hz), 164.86 
(d, 1JCF = 229.9 Hz), 163.63 163.50, 137.42, 134.30 (d, 4JCF = 3.0 Hz), 133.65 (d, 4JCF = 3.1 Hz), 131.07, 130.68 (d, 
3JCF = 8.7 Hz), 129.41 (d, 3JCF = 8.7 Hz), 129.09, 127.38, 116.11 (d, 2JCF = 21.8 Hz), 115.52 (d, 2JCF = 21.6 Hz), 109.90; 
19F NMR (376 MHz, CDCl3): δ 109.80 (m), 110.55 (m); HRMS (FAB+) m/z Calcd. for C22H15F2N2 [M+H]+ 345.1203, 
found 345.1206. 
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6-phenyl-2,4-bis[4-(trifluromethyl)phenyl]pyrimidine (6f). Synthesized using the general setup using 
phenylacetylene (10.8 µL, 0.0987 mmol), 4-(trifluoromethyl)benzonitrile (101.3 mg, 0.592 mmol) and 2 (5.0 mg, 4.9 
µmol) in toluene (3 mL), and purified via silica gel column chromatography (3% EtOAc/hexanes). White solid. First 
run 37.4 mg (85%) Second Run 38.1 mg (87%). 1H NMR (400 MHz, CDCl3): δ 8.79 (d, 3JHH = 8.4 Hz, 2H), 8.36 (d, 
3JHH = 8.2 Hz, 2H), 8.29 – 8.24 (m, 2H), 8.04 (s, 1H), 7.82 (d, 3JHH = 8.3 Hz, 2H), 7.78 (d, 3JHH = 8.3 Hz, 2H), 7.60 – 
7.56 (m, 3H); 13C{1H} NMR (101 MHz, CDCl3): δ 165.56, 163.60, 163.53, 141.17 (q, 4JCF = 1.1 Hz), 140.65 (q, 4JCF 
= 1.2 Hz)136.92, 136.92, 132.79 (q, 2JCF = 32.6 Hz), 132.55 (q, 2JCF = 32.3 Hz), 131.46, 129.22, 128.88, 127.76, 
127.44, 126.07 (q, 3JCF = 3.7 Hz), 125.57 (q, 3JCF = 3.7 Hz), 122.97, 122.72, 111.31; 19F NMR (376 MHz, CDCl3): δ 
62.66 (s), 62.77 (s). 
 
Catalytic controls 
Photoreduction of ZrBn4 in the presence of anthracene. A quartz Schlenk tube was charged with a Teflon-coated 
stir bar, ZrBn4 (50.0 mg, 0.110 mmol), anthracene (19.6 mg, 0.110 mmol) and tetrahydrofuran (1 mL). The flask was 
sealed and irradiated with light from a Xe arc lamp (75 W) with stirring at room temperature for 12 h forming a deep 
red brown suspension. The volatiles were removed in vacuo. 5 mg of the crude solid was then tested under the general 
catalytic conditions in place of 2.  
 
Photoreduction of ZrBn2Cl2 in the presence of anthracene. A thawing THF solution (0.5 mL) of ZrBn4 (25.0 mg, 
0.055 mmol) was added to a thawing THF suspension (0.5 mL) of ZrCl4 (12.8 mg, 0.055 mmol) with stirring. After 
warming the mixture to room temperature the suspension was transferred to a quartz Schlenk tube was and anthracene 
(19.6 mg, 0.110 mmol) added. The flask was sealed and irradiated with light from a Xe arc lamp (75 W) with stirring 
at room temperature for 12 h forming a deep red brown solution. The volatiles were removed in vacuo. 5 mg of the 
crude solid was then tested under the general catalytic conditions in place of 2. 
 
Reduction of ZrCl4 by Mg(THF)3(C14H10). Mg(THF)3(C14H10) (35.7 mg, 0.0859 mmol) was added to a thawing 
suspension of ZrCl4 (20.0 mg, 0.0859 mmol) and was allowed to warm to room temperature turning from orange to 
yellow then brown green. After 10 min at room temperature, the volatiles were removed under reduced pressure and 
the residue extracted with benzene. Concentration of the filtrate provided an off-white solid. 5 mg of the crude solid 
was then tested under the general catalytic conditions in place of 2. 
 
In-situ reduction of ZrCl4 by Mg(THF)3(C14H10). Following the general setup for catalysis, using ZrCl4 in place of 
2, Mg(THF)3(C14H10) (2.3 mg) was added as a last step before sealing and heating the mixture. 
 
In-situ reduction of ZrCl4 by KC8 in the presence of anthracene. Following the general setup for catalysis, using 
ZrCl4 in place of 2, anthracene (0.9 mg) and then KC8 (0.7 mg) was added as a last step before sealing and heating the 
mixture. 
 
Stoichiometric reactions from preformed (aza)zirconacyclopentadienes 3b and 5. To a solution 3b or 5 (20.0 mg) 
in C6D6 (0.5 mL) in a J. Young tube was added either phenylacetylene or benzonitrile (5 equiv.). The tube was sealed 
and heated in an oil bath at 90 °C for 1 h. 
 
 Figure S1. GC-MS chromatograph from reaction of 5 with benzonitrile (5 equiv.) after 1 h heating at 90 °C 
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 Figure S2. GC-MS chromatograph from reaction of 3b with benzonitrile (5 equiv.) after 1 h heating at 90 °C 
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NMR Spectra 
 
Figure S3. 1H NMR spectrum (400 MHz, CDCl3) of 1,3-dibromo-5-(tert-butyl)-2-(methoxymethoxy)benzene 
 
Figure S4. 13C{1H} NMR spectrum (101 MHz, CDCl3) of 1,3-dibromo-5-(tert-butyl)-2-
(methoxymethoxy)benzene 
 
Figure S5. 1H NMR spectrum (400 MHz, CDCl3) of 3-bromo-5-(tert-butyl)-2-(methoxymethoxy)-2',4',6'-
trimethyl-1,1'-biphenyl 
H2O 
H2O 
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Figure S6. 13C{1H} NMR spectrum (101MHz, CDCl3) of 3-bromo-5-(tert-butyl)-2-(methoxymethoxy)-2',4',6'-
trimethyl-1,1'-biphenyl 
 
Figure S7. 1H NMR spectrum (400 MHz, CDCl3) of anti-9,10-bis(5-(tert-butyl)-2-(methoxymethoxy)-2',4',6'-
trimethyl-[1,1'-biphenyl]-3-yl)anthracene 
 
Figure S8. 13C{1H} NMR spectrum (101MHz, CDCl3) of anti-9,10-bis(5-(tert-butyl)-2-(methoxymethoxy)-
2',4',6'-trimethyl-[1,1'-biphenyl]-3-yl)anthracene 
H2O 
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Figure S9. HSQC NMR spectrum of anti-9,10-bis(5-(tert-butyl)-2-(methoxymethoxy)-2',4',6'-trimethyl-[1,1'-
biphenyl]-3-yl)anthracene 
 
Figure S10. 1H NMR spectrum (400 MHz, CDCl3) of anti-3,3''-(anthracene-9,10-diyl)bis(5-(tert-butyl)-2',4',6'-
trimethyl-[1,1'-biphenyl]-2-ol) 
 
Figure S11. 13C{1H} NMR spectrum (101MHz, CDCl3) of anti-3,3''-(anthracene-9,10-diyl)bis(5-(tert-butyl)-
2',4',6'-trimethyl-[1,1'-biphenyl]-2-ol) 
H2O 
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Figure S12. 1H NMR spectrum (400 MHz, CDCl3) of syn-3,3''-(anthracene-9,10-diyl)bis(5-(tert-butyl)-2',4',6'-
trimethyl-[1,1'-biphenyl]-2-ol) (LH2) 
 
Figure S13. 13C{1H} NMR spectrum (101MHz, CDCl3) of syn-3,3''-(anthracene-9,10-diyl)bis(5-(tert-butyl)-
2',4',6'-trimethyl-[1,1'-biphenyl]-2-ol) (LH2) 
 
Figure S14. 1H NMR spectrum (400 MHz, C6D6) of 1 
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Figure S15. 13C{1H} NMR spectrum (101MHz, C6D6) of 1 
 
Figure S16. 1H NMR spectrum (400 MHz, C6D6) of 2 
 
Figure S17. 13C{1H} NMR spectrum (101MHz, C6D6) of 2 
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Figure S18. 1H NMR spectrum (400 MHz, C6D6) of 3a 
 
Figure S19. 13C{1H} NMR spectrum (101MHz, C6D6) of 3a 
 
Figure S20. 1H NMR spectrum (400 MHz, C6D6) of 3b 
S17 
 
 
Figure S21. 13C{1H} NMR spectrum (101MHz, C6D6) of 3b 
 
Figure S22. 1H NMR spectrum (400 MHz, C6D6) of 4 
 
Figure S23. 13C{1H} NMR spectrum (101MHz, C6D6) of 4 
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Figure S24. 1H NMR spectrum (400 MHz, C6D6) of 5 
 
Figure S25. 13C{1H} NMR spectrum (101MHz, C6D6) of 5. 
 
Figure S26. 1H NMR spectrum (400 MHz, CDCl3) of 6a 
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Figure S27. 1H NMR spectrum (400 MHz, CDCl3) of 6b 
 
Figure S28. 1H NMR spectrum (400 MHz, CDCl3) of 6c 
 
Figure S29. 13C{1H} NMR spectrum (101 MHz, CDCl3) of 6c 
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Figure S30. 1H NMR spectrum (400 MHz, CDCl3) of 6d 
 
Figure S31. 1H NMR spectrum (400 MHz, CDCl3) of 6e 
 
Figure S32. 13C{1H} NMR spectrum (101 MHz, CDCl3) of 6e 
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Figure S33. 19F NMR spectrum (376 MHz, CDCl3) of 6e  
 
Figure S34. 1H NMR spectrum (400 MHz, CDCl3) of 6f 
 
Figure S35. 13C{1H} NMR spectrum (101 MHz, CDCl3) of 6f 
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Figure S36. 19F NMR spectrum (376 MHz, CDCl3) of 6f 
 
 
 
 
  
triazine 
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Table S1. Additional substrates screened under optimized catalytic conditions.a 
Entry Alkyne Nitrile Productsb (Yieldsc) 
1   nd 
2   
(<5%) 
3   nd 
4  nd 
5     nd 
6    
(<5%) 
7     nd 
8     nd 
9    
(<5%) 
10     nd 
11     nd 
12    
(37%) 
aoptimized conditions: 6:1 nitrile:alkyne, 5 mol% 3a, toluene (3 mL), 105 °C, 1h; bnd: not detected by 
GC-MS; cyields approximated from GC-MS based on PhCCH or PhCN consumption.  
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Crystallographic Information 
 
CCDC deposition numbers 1853068, 1853069 and 1853070 contain the supplementary crystallographic data for this 
paper.8 These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
 
Refinement Details. In each case, crystals were mounted on a glass fiber or MiTeGen loop using Paratone oil, then 
placed on the diffractometer under a nitrogen stream. Low temperature (100 K) X-ray data were obtained on a Bruker 
D8 VENTURE Kappa Duo PHOTON 100 CMOS based diffractometer (Mo IμS HB micro-focus sealed X-ray tube, 
Kα = 0.71073 Å OR Cu IμS HB micro-focused X-ray tube, Kα = 1.54178). All diffractometer manipulations, including 
data collection, integration, and scaling were carried out using the Bruker APEXII software.9 Absorption corrections 
were applied using SADABS.10 Space groups were determined on the basis of systematic absences and intensity 
statistics and the structures were solved in the Olex 2 software interface11 by intrinsic phasing using XT (incorporated 
into SHELXTL)12 and refined by full-matrix least squares on F2. All non-hydrogen atoms were refined using 
anisotropic displacement parameters, except in some cases with heavily distorted solvent. Hydrogen atoms were 
placed in the idealized positions and refined using a riding model. The structure was refined (weighed least squares 
refinement on F2) to convergence. Graphical representation of structures with 50% probability thermal ellipsoids were 
generated using Diamond 3 visualization software.13 Structure of 5 was not submitted to CCDC due to poor quality. 
 
Special Refinement Details for 1. 1 crystallizes in a P-1 space group with one molecule in the asymmetric cell along 
with 1 cocrystallized molecule of pentane. Part of the pentane molecule was disordered over 2 positions (occupancies 
71% and 29%). There is additional solvent disorder which could not be satisfactorily modelled and was masked in 
Olex2. The volume of the solvent accessible void space was found to be 233.7 Å3 in which 32.5 e- were located. 
 
Special Refinement Details for 2. 2 crystallizes in a P-1 space group with one molecule in the asymmetric cell along 
with 1.6 cocrystallized molecules of tetrahydrofuran and 0.4 cocrystallized molecules of pentane. The pentane solvent 
is positionally disordered with a tetrahydrofuran molecule (44% and 56% occupancies, respectively). Part of the other 
tetrahydrofuran molecule was disordered over 2 positions (occupancies 87% and 13%), with the smaller part refined 
isotropically.  
 
Special Refinement Details for 3a. 3a crystallizes in the P-1 space group with one molecule in the asymmetric cell 
along with 1 cocrystallized molecule of pentane and 0.5 cocrystallized molecule of toluene. Both tert-butyl groups of 
the ligand are positionally disordered (69% and 31%, and 92% and 8% occupancies), with the former having bonds 
retained to be equal. The minor 8% part was refined isotropically. 3 of the 4 phenyl groups bound to the 
zirconacyclopentadiene motif are disordered over 2 positions and model with the same free varible (occupancies 51% 
and 49%).   Due to the disorder the solvent molecules were refined isotropically. The toluene solvent is disorder with 
a pentane solvent (both fixed at 50% occupancy) while another pentane molecule is positionally disordered at a 
symmetry element (occupancy 50%) restraining bonds to be equal. 
 
   
S25 
 
Table S2. Crystal data and structure refinement for 1, 2, 3a and 5 
 1 2 3a 5 
CCDC Number8 1853068 1853069 1853070 - 
Empirical formula C71H78O2Zr C72.44H93.75O6.57Zr C92.42H96.5O3Zr C77H85NO3Zr 
Formula weight 1054.55 1160.69 1346.44 1163.67 
Temperature/K 100.15 100 100.0 100.02 
Crystal system triclinic triclinic triclinic monoclinic 
Space group P-1 P-1 P-1 P21/c 
a/Å 11.101(4) 12.4092(6) 12.350(2) 13.2545(11) 
b/Å 12.844(4) 12.7750(8) 12.845(2) 25.037(2) 
c/Å 21.787(7) 20.5948(17) 27.404(4) 19.9334(16) 
α/° 101.462(14) 93.281(3) 78.961(7) 90 
β/° 99.260(9) 103.293(4) 80.374(5) 107.996(3) 
γ/° 93.809(11) 99.373(3) 63.052(12) 90 
Volume/Å3 2989.4(17) 3119.7(4) 3787.6(11) 6291.2(9) 
Z 2 2 2 4 
ρcalcg/cm3 1.172 1.236 1.181 1.229 
μ/mm-1 0.227 0.229 0.195 1.803 
Crystal size/mm3 0.4 × 0.2 × 0.1 0.22 × 0.16 × 0.11 0.25 × 0.25 × 0.09 0.09 × 0.05 × 0.03 
Radiation MoKα (λ = 0.71073) MoKα (λ = 0.71073) MoKα (λ = 0.71073) CuKα (λ = 1.54178) 
2Θ range/° 4.698 to 61.314 4.398 to 73.656 4.58 to 69.918 5.848 to 105.636 
GOF 1.057 1.038 1.147 1.065 
R1,a wR2b [I>2 σ(I)] 0.0396, 0.0990 0.0423, 0.0902 0.0661, 0.1721 0.0979, 0.2382 
aR1 = Σ||F0| − |Fc||/Σ|F0|. b wR2 = [Σ[w(F02−Fc2)2]/Σ[w(F02)2]1/2 
 
 
Figure S37. Solid-state structure of 5; thermal ellipsoids shown at 50% probability. Solvent molecules and 
hydrogen atoms omitted for clarity; relevant bond distances (Å): Zr1–O1 1.984(7), Zr1–O2 1.981(7), Zr1–C57 
2.27(1), Zr1–N1 2.043(9), C57–C58 1.34(1), C58–C59 1.46(2), C59–N1 1.27(1) 
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